Moderna vs Modal
Side-by-side comparison of AI visibility scores, market position, and capabilities
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
About
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Serverless GPU cloud platform for AI/ML with Python-native deployment and per-second billing; developer-favorite scaling from zero competing with Replicate and Beam for AI compute.
About
Modal is a serverless cloud computing platform purpose-built for AI and machine learning workloads — providing on-demand GPU compute that scales instantly from zero with per-second billing, container management, distributed training support, and a Python-native developer experience that makes running ML workloads in the cloud feel as simple as running code locally. Founded in 2021 in New York City and backed by Redpoint Ventures and other investors, Modal has grown rapidly as AI development has accelerated demand for flexible, developer-friendly GPU infrastructure.\n\nModal's developer experience is its primary differentiator — engineers write Python functions decorated with @modal.function() and deploy them to the cloud with a single command, with Modal handling container building, GPU provisioning, auto-scaling, and execution. The platform supports training jobs that need distributed compute across multiple GPUs, model serving endpoints that scale to zero when unused (eliminating idle GPU costs), and batch inference jobs that process large datasets. The per-second billing model means developers pay only for actual compute time, not provisioned instances.\n\nIn 2025, Modal competes in the AI infrastructure market with Replicate, Beam, Banana, and major cloud providers' managed ML services (AWS SageMaker, Google Vertex AI, Azure ML) for serverless GPU compute. The market for AI-specific cloud infrastructure has grown dramatically as the number of ML engineers deploying models to production has expanded — traditional cloud providers require significant DevOps expertise to use GPU instances effectively, while Modal's Python-native approach reduces the barrier to entry. Modal has attracted a strong developer following among AI researchers and ML engineers building production AI applications. The 2025 strategy focuses on growing the developer community, adding enterprise features (dedicated GPU capacity, private networking, compliance), and expanding the hardware options available (H100 GPUs, custom accelerators).
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.